RFC
NAVB

Russell Frank Company’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Russell Frank Company’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$67K Buy
+3,510
New +$67.5K ﹤0.01% 2830
2013
Q4 		– Sell
-612
Closed -$32K – 3209
2013
Q3 		$32K Buy
612
+255
+71% +$14.9K ﹤0.01% 3193
2013
Q2 		$19K Buy
+357
New +$17.8K ﹤0.01% 3012

Other funds holding NAVB

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Russell Frank Company's NAVB Position: Q1 2016 in Review

Russell Frank Company opened a new position in Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2016: 3,510 shares worth $67K. The stake represents ﹤0.01% of the portfolio and ranks #2830 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in NAVB as recently as Q3 2013.

Russell Frank Company first reported a position in NAVB in Q2 2013 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold NAVB as of Q1 2016.

  • Russell Frank Company held 3,510 shares of Navidea Biopharmaceuticals Inc. worth $67K as of Q1 2016.
  • Navidea Biopharmaceuticals Inc. was a new Russell Frank Company position in Q1 2016.
  • Navidea Biopharmaceuticals Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2830 holding.
  • Russell Frank Company first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.